Krause B J, Beyer T, Bockisch A, Delbeke D, Kotzerke J, Minkov V, Reiser M, Willich N
Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität, Ismaninger Strasse 22, 81675 Munich.
Nuklearmedizin. 2007;46(6):291-301. doi: 10.3413/nukmed-282.
FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the past decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FDG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented.
氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描（FDG-PET/CT）检查在一个整合程序中结合了代谢成像和形态学成像。在过去十年中，PET/CT成像在肿瘤学领域已获得广泛的临床认可。本FDG-PET/CT指南聚焦于德国特定临床和社会背景下肿瘤患者FDG-PET/CT检查的适应证、数据采集与处理以及记录。背景信息和定义之后是FDG-PET/CT临床和研究应用的实例。此外，还讨论了CT扫描（低剂量CT和增强CT）及PET发射成像的方案。明确了检查的记录与报告。讨论了图像解读标准和误差来源。介绍了FDG和PET/CT系统的质量控制、人员资质要求以及法律方面的内容。
